These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18562337)

  • 1. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.
    Han B; Bojalil R; Amezcua-Guerra LM; Springall R; Valderrama-Carvajal H; Wu J; Luo H
    Int Immunol; 2008 Aug; 20(8):1067-75. PubMed ID: 18562337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
    Han B; Moore PA; Wu J; Luo H
    Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus.
    Lee CS; Hu CY; Tsai HF; Wu CS; Hsieh SL; Liu LC; Hsu PN
    Clin Exp Immunol; 2008 Mar; 151(3):383-90. PubMed ID: 18190609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DcR3 mutations in patients with juvenile-onset systemic lupus erythematosus lead to enhanced lymphocyte proliferation.
    Chokdeemeeboon C; Ammarinthnukrowh P; Tongkobpetch S; Srichomtong C; Deekajorndech T; Rianthavorn P; Kingwattanakul P; Avihingsanon Y; Wright HL; Akkahat P; Hoven VP; Mekboonsonglarp W; Edwards SW; Hirankarn N; Suphapeetiporn K; Shotelersuk V
    J Rheumatol; 2013 Aug; 40(8):1316-26. PubMed ID: 23729807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoy receptor 3 attenuates collagen-induced arthritis by modulating T cell activation and B cell expansion.
    Cheng CP; Sytwu HK; Chang DM
    J Rheumatol; 2011 Dec; 38(12):2522-35. PubMed ID: 21885501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus.
    Levite M; Zinger H; Zisman E; Reisner Y; Mozes E
    Cell Immunol; 1995 Apr; 162(1):138-45. PubMed ID: 7704902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
    Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
    Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
    Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
    Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia.
    Kuwana M; Okazaki Y; Kajihara M; Kaburaki J; Miyazaki H; Kawakami Y; Ikeda Y
    Arthritis Rheum; 2002 Aug; 46(8):2148-59. PubMed ID: 12209520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice.
    Ka SM; Sytwu HK; Chang DM; Hsieh SL; Tsai PY; Chen A
    J Am Soc Nephrol; 2007 Sep; 18(9):2473-85. PubMed ID: 17687076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoy receptor 3 protects non-obese diabetic mice from autoimmune diabetes by regulating dendritic cell maturation and function.
    Wang YL; Chou FC; Sung HH; Fan PL; Hsueh CW; Lin WC; Chen SJ; Lin WW; Sytwu HK
    Mol Immunol; 2010 Oct; 47(16):2552-62. PubMed ID: 20801512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
    Mueller AM; Pedré X; Killian S; David M; Steinbrecher A
    J Neuroimmunol; 2009 Apr; 209(1-2):57-64. PubMed ID: 19269042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis.
    Bamias G; Kaltsa G; Siakavellas SI; Papaxoinis K; Zampeli E; Michopoulos S; Zouboulis-Vafiadis I; Ladas SD
    Clin Immunol; 2010 Nov; 137(2):242-9. PubMed ID: 20675196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes.
    Lee TP; Tang SJ; Wu MF; Song YC; Yu CL; Sun KH
    J Autoimmun; 2010 Dec; 35(4):358-67. PubMed ID: 20833510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased CCR4 expression in active systemic lupus erythematosus.
    Hase K; Tani K; Shimizu T; Ohmoto Y; Matsushima K; Sone S
    J Leukoc Biol; 2001 Nov; 70(5):749-55. PubMed ID: 11698495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients.
    Rastin M; Hatef MR; Tabasi N; Sheikh A; Morad Abbasi J; Mahmoudi M
    Iran J Immunol; 2007 Jun; 4(2):110-5. PubMed ID: 17652851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.